Back

Prognostic value of GDF-15 in patients with suspected myocardial infarction

1 September 2025 (15:20 - 15:30)
Organised by: Logo
Congress Presentation Part of: Novel biomarkers for cardiovascular risk assessment Biomarkers ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Jonas Lehmacher

University Heart and Vascular Centre Hamburg (UHZ), Hamburg (Germany)

3 More presentations in this session

Presentation thumbnail
Incident CHD, residual risk and traditional cardiovascular risk factors in the community: role of lipid-inflammatory axis
Doctor N. Arnold (Hamburg, DE)
Abstract Slides
Presentation thumbnail
Association between genetic polymorphisms in multiple thrombosis-related genes and long-term prognosis in coronary artery disease patients: a large-scale cohort study
Miss K. Zhang (Beijing, CN)
Abstract Slides
Presentation thumbnail
Cholesterol efflux capacity and subclinical atherosclerosis: is its impact greater in early stages?
Doctor W. Skoza (Madrid, ES)
Abstract Slides

Access the full session

Session thumbnail
Novel biomarkers for cardiovascular risk assessment
Video

The Event

Event poster

ESC Congress 2025

1 September 2025 15:20 CET
You may be interested in
thumbnail
Congress Presentation
Association between GDF-15 levels and cardiac morphology and function in cardiac magnetic resonance imaging: insights from UK Biobank data analysis
thumbnail
Congress Presentation
Beyond NT-proBNP: novel biomarkers enhance short- and intermediate-term risk prediction in tricuspid valve interventions
thumbnail
Congress Presentation
The prognostic value of GDF15 in patients with heart failure and coronary artery disease after coronary artery bypass grafting

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources